Prevalence and Clinical Characteristics of the Metabolic Syndrome in Middle-aged Korean Adults

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 2006 Feb 24

PMID 16491829

Citations 29

Authors

Hyuk Sang Kwon

Yong Moon Park

Hye Jung Lee

Jin Hee Lee

Yoon Hee Choi

Seung Hyun Ko

Jung Min Lee

Sung Rae Kim

So Young Kang

Won Chul Lee

Myung Sook Ahn

Jae Hong Noh

Jin Mo Kang

Dong Suk Kim

Kun Ho Yoon

Bong Yun Cha

Kwang Woo Lee

Sung Koo Kang

Ho Young Son

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to analyze the prevalence and clinical characteristic of the metabolic syndrome of adults, over 40 years old, living in Korea.

Methods: This study was carried out for 2 years, 2003-2004, on total 5,330 individuals (2,197 men and 3,133 women) selected by the stratified random cluster sampling among adults over 40 years old. Metabolic syndrome was defined based on both the NCEP-ATP III criteria and Modified ATP III criteria applying the WHO-APR (Asian Pacific Region)'s abdominal obesity criteria (waist circumference > 90 cm in men, 80 cm in women) instead of NCEP-ATP III criteria.

Results: Using NCEP-ATP III criteria, the age-adjusted overall prevalence of metabolic syndrome was 24.8% (17.6% in men, 30.0% in women). Age-adjusted overall prevalence of metabolic syndrome as defined by modified-ATP III criteria was 34.3% (26.3% in men, 40.1% in women). The prevalence of metabolic syndrome for each age group (40-49, 50-59, 60-69, > or = 70) in men was as follows: 18.8%, 17.4%, 18.3%, 14.5%. In women: 22.3%, 32.7%, 39.9%, 39.3%. The prevalence of hypertriglyceridemia (triglycerides > or = 1.7 mmol/l) was well correlated with the changing pattern of the prevalence of metabolic syndrome both in men and women.

Conclusions: The peak age of metabolic syndrome in men was age 40 through 49, and the prevalence decreased with aging. Therefore, early intervention for risk factors of metabolic syndrome might be required in men. On the other hand, prevention for cardiovascular disease will be needed for perimenopausal women due to considerably increased prevalence in the age 50 through 59.

Citing Articles

Hypovitaminosis D and Metabolic Syndrome in Postmenopausal Women.

Abuhijleh H, Alkhatib D, Ganji V Healthcare (Basel). 2022; 10(10).

PMID: 36292473 PMC: 9602081. DOI: 10.3390/healthcare10102026.

Relation of Dietary n-3 and n-6 Fatty Acid Intakes to Metabolic Syndrome in Middle-Aged People Depending on the Level of HbA1c: A Review of National Health and Nutrition Survey Data from 2014 to 2016.

Park S, Kim D, Bak G, Hyun D, Kim S Medicina (Kaunas). 2022; 58(8).

PMID: 36013484 PMC: 9413490. DOI: 10.3390/medicina58081017.

Nutritional and lifestyle intervention strategies for metabolic syndrome in Southeast Asia: A scoping review of recent evidence.

Thor S, Yau J, Ramadas A PLoS One. 2021; 16(9):e0257433.

PMID: 34520483 PMC: 8439470. DOI: 10.1371/journal.pone.0257433.

Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Lee S, Kwon H, Kang M, Park Y, Park J, Lee S Rheumatol Int. 2021; 42(2):291-302.

PMID: 34086074 DOI: 10.1007/s00296-021-04908-1.

Biological age and lifestyle in the diagnosis of metabolic syndrome: the NHIS health screening data, 2014-2015.

Bae C, Piao M, Kim M, Im Y, Kim S, Kim D Sci Rep. 2021; 11(1):444.

PMID: 33431923 PMC: 7801435. DOI: 10.1038/s41598-020-79256-4.

References

King H, Rewers M . Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993; 16(1):157-77. DOI: 10.2337/diacare.16.1.157. View

Reaven G . Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993; 44:121-31. DOI: 10.1146/annurev.me.44.020193.001005. View

Wang J, Thornton J, Russell M, Burastero S, Heymsfield S, Pierson Jr R . Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994; 60(1):23-8. DOI: 10.1093/ajcn/60.1.23. View

Garg A . Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care. 1996; 19(4):387-9. DOI: 10.2337/diacare.19.4.387. View

Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

Joffe B, Zimmet P . The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale?. Endocrine. 1998; 9(2):139-41. DOI: 10.1385/ENDO:9:2:139. View

Balkau B, Charles M . Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16(5):442-3. DOI: 10.1046/j.1464-5491.1999.00059.x. View

Ford E, Giles W, Dietz W . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287(3):356-9. DOI: 10.1001/jama.287.3.356. View

DeFronzo R, Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14(3):173-94. DOI: 10.2337/diacare.14.3.173. View

10.

Karelis A, St-Pierre D, Conus F, Rabasa-Lhoret R, Poehlman E . Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab. 2004; 89(6):2569-75. DOI: 10.1210/jc.2004-0165. View

11.

Lee W, Park J, Noh S, Rhee E, Kim S, Zimmet P . Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract. 2004; 65(2):143-9. DOI: 10.1016/j.diabres.2003.12.007. View

12.

Olefsky J, Farquhar J, Reaven G . Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med. 1974; 57(4):551-60. DOI: 10.1016/0002-9343(74)90006-0. View

13.

McKeigue P, Shah B, Marmot M . Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991; 337(8738):382-6. DOI: 10.1016/0140-6736(91)91164-p. View

14.

. Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev. 2001; 17(5):347-62. DOI: 10.1002/dmrr.230. View

15.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

16.

Deurenberg P, Deurenberg-Yap M, Guricci S . Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002; 3(3):141-6. DOI: 10.1046/j.1467-789x.2002.00065.x. View

17.

Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V . Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003; 60(3):199-204. DOI: 10.1016/s0168-8227(03)00060-3. View

18.

Carr M . The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 88(6):2404-11. DOI: 10.1210/jc.2003-030242. View

19.

Haffner S . Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract. 2003; 61 Suppl 1:S9-S18. DOI: 10.1016/s0168-8227(03)00122-0. View

20.

Einhorn D, Reaven G, Cobin R, Ford E, Ganda O, Handelsman Y . American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003; 9(3):237-52. View